2014

Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Six-Months Ended June 30, 2012

ST. LOUIS, July 23, 2012 /PRNewswire/ -- Young Innovations, Inc. (NASDAQ – YDNT) today announced record sales and earnings per share for the second quarter and the six-months ended June 30, 2012.

Sales for the second quarter of 2012 were $28.1 million, an increase of 2.7% over the $27.3 million reported for the second quarter of 2011. Income from operations increased 5.8% to $6.6 million from $6.2 million in the prior year. Net income for the second quarter increased 8.4% to $4.4 million from $4.0 million for the second quarter of 2011. Diluted earnings per share for the second quarter of 2012 were $0.56, an increase of 12.0% over the $0.50 reported in the prior year quarter.

For the six months ended June 30, 2012, sales were $54.8 million, increasing 2.7% from the $53.4 million reported in the prior year period. Income from operations increased 5.6% to $12.6 million from $12.0 million in the prior year six-month period. Net income was $8.6 million, increasing 7.0% from $8.0 million in the prior year six-month period. Diluted earnings per share were $1.09 for the six months ended June 30, 2012, an increase of 9.0% from $1.00 in the same period of 2011.

We are pleased with the Company's sales performance in the quarter. Strong growth of our diagnostic product line and solid demand for our consumables products drove a healthy overall increase for the second quarter.  A stronger US dollar negatively impacted sales in the second quarter by $217,000. During the quarter, the Company also recognized a gain from its investment in a private equity fund of $208,000 which was recorded as "other income." In the second quarter of 2011, the Company recorded a gain of $50,000 from this same fund. 

During the second quarter, we focused on several key initiatives to drive future growth. We implemented targeted marketing campaigns and promotional activity to support several recently introduced products. We also continued to make progress in the development of new products across the business. Furthermore, we invested in new equipment and systems upgrades to support future growth. Finally, we ended the quarter with $9.1 million of cash on our balance sheet, up from $5.2 million on March 31, 2012. While we remain cautious due to ongoing global economic uncertainty, we are encouraged by our progress in the first half of the year.

A conference call has been scheduled for Tuesday, July 24, 2012 at 11:00 A.M. Central Time and can be accessed through InterCall at http://tinyurl.com/YI-Quarter22012 or the Company's website, www.ydnt.com.

Young Innovations develops, manufactures and markets supplies and equipment used by dentists, dental hygienists, dental assistants and consumers. The Company's consumables product offering includes disposable and metal prophy angles, prophy cups and brushes, dental micro-applicators, moisture control products, infection control products, dental handpieces (drills) and related components, endodontic systems, orthodontic toothbrushes, flavored examination gloves, children's toothbrushes, and children's toothpastes. In addition, the Company offers a line of diagnostic products that includes panoramic X-ray machines and related supplies. The Company believes it is a leading U.S. manufacturer or distributor of prophy angles and cups, liquid surface disinfectants, dental micro-applicators and obturation units designed for warm, vertical condensation.

Investors are cautioned that this press release as well as other reports and oral statements by Company officials may contain certain forward-looking statements as defined in the Private Securities Litigation and Reform Act of 1995.  Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions and which include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," or similar expressions.  These statements are not guarantees of future performance and the Company makes no commitment to update or disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that may bear upon forward-looking statements.  Because such statements involve risks and uncertainties, actual actions and strategies and the timing and expected results thereof may differ materially from those expressed or implied by such forward-looking statements.  These risks and uncertainties include, but are not limited to, those disclosed in the Company's Annual Report on Form 10-K and other reports filed with the Securities and Exchange Commission.

Young Innovations, Inc.

Consolidated Statements of Income

(In thousands, except earnings per share data)

(Unaudited)

(In Thousands USD)












Three Months Ended



Six Months Ended



June 30,



June 30,



2012


2011

Change


2012


2011

Change











Net Sales

$28,054


$27,326

2.7%


$54,808


$53,351

2.7%

Cost of Goods Sold

$12,453


$12,178

2.3%


$24,215


$23,740

2.0%

Gross Profit

$15,601


$15,148

3.0%


$30,593


$29,611

3.3%

% of Net Sales

55.6%


55.4%



55.8%


55.5%












Selling, General and Administrative Expense

$  9,040


$  8,945

1.1%


$17,958


$17,641

1.8%

% of Net Sales

32.2%


32.7%



32.8%


33.1%












Income from Operations

6,561


6,203

5.8%


12,635


11,970

5.6%

% of Net Sales

23.4%


22.7%



23.1%


22.4%












Interest expense, net

(58)


(54)



(113)


(128)


Other income (expense), net

248


34



742


468












Income Before Taxes

6,751


6,183

9.2%


13,264


12,310

7.7%











Provision for Income Taxes

2,374


2,146



4,664


4,273












Net Income

$  4,377


$  4,037

8.4%


$  8,600


$  8,037

7.0%

% of Net Sales

15.6%


14.8%



15.7%


15.1%












Basic Earnings Per Share 

$    0.56


$    0.50

12.0%


$    1.09


$    1.00

9.0%











Basic Weighted Average Shares Outstanding

7,868


8,012



7,877


8,011












Earnings Per Share (Diluted)

$    0.56


$    0.50

12.0%


$    1.09


$    1.00

9.0%











Diluted Weighted Average Shares Outstanding

7,872


8,064



7,882


8,069


YI Consolidated

Consolidated Balance Sheet

June 30, 2012 and December 31, 2011

(In Thousands USD)







(Unaudited)







June 30


December 31

Assets



2012


2011

Current assets







Cash



$        9,084


$           1,031


Accounts receivable, net



12,858


12,066


Inventories



16,596


17,161


Other current assets



4,783


4,729

Total current assets



43,321


34,987








Property, plant and equipment, net



31,515


32,272

Goodwill



80,226


80,254

Intangible assets



10,888


11,130

Other assets



819


1,143








Total assets



$    166,769


$       159,786








Liabilities and Equity






Current liabilities







Accounts payable and accrued liabilities



$        9,641


$           9,134

Total current liabilities



9,641


9,134








Long-term debt



-


650

Long-term secured borrowing



7


9

Deferred income taxes



19,333


19,534

Other noncurrent liabilities



203


206

Total liabilities



29,184


29,533








Stockholders' equity







Common stock



102


102


Additional paid-in capital



24,679


24,708


Retained earnings



166,619


158,647


Common stock in treasury, at cost



(53,453)


(52,924)


Accumulated other comprehensive (loss)



(362)


(280)

Total stockholders' equity



137,585


130,253








Total liabilities and stockholders' equity



$    166,769


$       159,786

SOURCE Young Innovations, Inc.



RELATED LINKS
http://www.ydnt.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.